Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | IDH1 | O75874 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5236820 | 0.85 | DHODH (0.37) | ALDH1A1IDH1 | |
| SCHEMBL14559306 | 0.83 | TP53 (0.34) | IDH1 | |
| SCHEMBL5744921 | 0.81 | — | — | |
| SCHEMBL5745324 | 0.81 | RORC (0.33) | — | |
| SCHEMBL4818612 | 0.81 | MAPK1 (0.35) | KDM4EALDH1A1HPGD | |
| SCHEMBL976390 | 0.81 | MAPK1 (0.35) | KDM4EALDH1A1HPGD | |
| SCHEMBL343322 | 0.81 | MAPK1 (0.35) | KDM4EALDH1A1HPGD | |
| SCHEMBL5745486 | 0.79 | KDM4E (0.36) | KDM4EALDH1A1HPGDHSD17B10SMN1; SMN2 | |
| SCHEMBL5233667 | 0.76 | CCNT1 (0.32) | IDH1 | |
| SCHEMBL14596578 | 0.76 | KMT2A (0.37) | KDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392695-B1 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2006-10-04 | — | — | EP | disclosed |
| US-20040157863-A1 | Triazolopyrimidines | BAYER CROPSCIENCE AG (DE) | 2004-08-12 | — | — | US | disclosed |
| EP-1392695-A2 | TRIAZOLOPYRIMIDINES | Bayer CropScience AG (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002088127-A2 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE AG (DE) | 2002-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157863-A1 | Triazolopyrimidines | Q6ZSR9, UMPS, MRPL21 | KDM4E 3275/4885ALDH1A1 273/4885HPGD 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.